TG Therapeutics
NasdaqCM:TGTX
$ 29,27
+ $0,24 (0,83%)
29,27 $
+$0,24 (0,83%)
End-of-day quote: 03/06/2026

Quick Analysis

$2,77
Earnings Per Share
-
Revenue Per Share
83,66%
Gross Margin %
$4,32 B
Market Cap
$0,25 B
Long-Term Debt
Earnings Per Share
$2,77
Revenue Per Share
-
Gross Margin %
83,66%
Market Cap
$4,32 B
Long-Term Debt
$0,25 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
EPS Earnings Per Share $2,77 $0,15 $0,09 $-1,46 $-2,63 $-2,42 $-1,96 $-2,30 $-1,91 $-1,60 $-1,38 $-1,64 $-0,70 $-1,17
Earnings Earnings $402,29M $21,78M $13,03M $-200,94M $-343,98M $-314,12M $-200,53M $-178,87M $-132,21M $-77,23M $-64,43M $-65,83M $-19,14M $-22,45M
RPS Revenue Per Share $0,00 N/A $2,27 $1,61 $0,02 $0,05 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,01 $0,00
Revenue Revenue $0,00M $616,29M $329,00M $233,66M $2,79M $6,69M $0,15M $0,15M $0,15M $0,15M $0,15M $0,15M $0,15M $0,15M $0,02M
OCF Operating Cash Flow $0,00M $493,00M $-40,52M $-31,41M $-176,17M $-295,52M $-214,51M $-133,78M $-128,93M $-93,76M $-61,59M $-44,69M $0,00M $-10,82M $0,00M
FCF Free Cash Flow $0,00M $437,30M $-40,56M $40,03M $-176,18M $-296,04M $-214,86M $-133,91M $-129,02M $-93,77M $-61,94M $-44,73M $0,00M $-10,83M $0,00M
OM Operating Margin 0,00% 20,01% 12,74% 8,83% -69,24% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 83,66% 88,30% 93,95% 90,48% 88,19% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00%
FCFS Free Cash Flow Per Share $0,00 $-0,17 $-0,28 $-0,22 $-1,30 $-2,24 $-1,86 $-1,50 $-1,71 $-1,51 $-1,26 $-0,98 $-1,03 $-0,42 $-0,40
LT Debt Long-Term Debt N/A $245,65M $244,43M $100,12M $71,14M $66,79M $7,72M $28,97M N/A N/A N/A N/A N/A $0,06M $2,48M
Sha. Stocks 147,68M 143,52M 145,23M 144,78M 137,63M 130,79M 129,8M 102,31M 77,77M 69,22M 48,27M 46,69M 40,14M 27,34M 19,19M
×